If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 381.00
Bid: 380.50
Ask: 382.00
Change: -0.50 (-0.13%)
Spread: 1.50 (0.394%)
Open: 379.50
High: 384.50
Low: 379.50
Prev. Close: 381.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 May 2023 16:52

RNS Number : 9444Z
Breedon Group PLC
18 May 2023
 

18 May 2023

Breedon Group plc (the "Company")

Directors' and PDMRs' Dealings

 

The Company announces that, on 16 May 2023, certain persons discharging managerial responsibilities were granted rollover conditional share awards under the terms of the Breedon PSPs and rollover options under the terms of the Breedon UK SAYE Plans, in each case in respect of ordinary shares of £1.40 each in the capital of the Company. These grants were undertaken in accordance with the procedures set out in the prospectus published by the Company on 11 May 2023 (the "Prospectus") and the scheme document published by Breedon Group plc (a company incorporated in Jersey with registered number 98465) on 29 March 2023 (the "Scheme Document").

The exercise price for each rollover option granted under the Breedon UK SAYE Plans is set out below. The rollover options are generally exercisable at any time within six months following the maturity of the relevant SAYE contract. The rollover conditional share awards granted under the terms of the Breedon PSPs are "nil-cost" awards and are subject to the same vesting terms and performance conditions as applied to the preceding conditional share awards that they replace. Further information in relation to these arrangements can be found in the Prospectus and the Scheme Document.

Defined terms used in this announcement have the meanings ascribed to them in the Prospectus, unless otherwise stated.

 

Enquiries:

 

Breedon Group plc www.breedongroup.com 

James Atherton-Ham, Group General Counsel +44 (0) 1332 694010

Louise Turner-Smith, Head of Investor Relations +44 (0) 7860 911909

 

MHP (Public Relations Adviser)  +44 (0) 20 3128 8193

Reg Hoare

Rachel Farrington

Charles Hirst

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rob Wood

2

Reason for Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary Shares of £1.40 each

Identification code

 

GB00BM8NFJ84

 

b)

Nature of the transaction

Grant of the following rollover conditional share awards and options in connection with the Scheme:

 

1. Rollover 2020 Breedon PSP award

 

2. Rollover 2021 Breedon PSP award

 

3. Rollover 2022 Breedon PSP award

 

4. Rollover 2023 Breedon PSP award

 

5. Rollover 2019 5yr Breedon UK SAYE Plan option

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

 

2. Nil

 

3. Nil

 

4. Nil

 

5. £2.75

 

1. 131,410

 

2. 171,812

 

3. 229,477

 

4. 271,552

 

5. 10,909

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Total Aggregate Volume

N/a

815,160

815,160

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

London Stock Exchange plc

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Brotherton

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary Shares of £1.40 each

Identification code

 

GB00BM8NFJ84

 

b)

Nature of the transaction

Grant of the following rollover conditional share awards and options in connection with the Scheme:

 

1. Rollover 2021 Breedon PSP award

 

2. Rollover 2022 Breedon PSP award

 

3. Rollover 2023 Breedon PSP award

 

4. Rollover 2021 5yr Breedon UK SAYE Plan option

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

 

2. Nil

 

3. Nil

 

4. £3.56

 

 

1. 99,601

 

2. 155,223

 

3. 183,684

 

4. 8,426

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Total Aggregate Volume

N/a

446,934

446,934

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

London Stock Exchange plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFFFIAEDSEII
Date   Source Headline
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022
18th Jul 20224:37 pmRNSStandard form for notification of major holdings
7th Jul 20223:49 pmRNSBlocklisting Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.